ISSN: 2574-7797
Authors: Abreu JM*
The stirrer reactor govern the industrial pharmaceutical productions up to the present, however the complex transmission systems may increase the costs exponentially with the power rates and the hermetic rector sealing. G-reactor improves the analogous reactors with simple pneumatic power device to heavy duty performances at high technological risks by pathogens and per substitution of complex transmissions by own-design; a single compression unit produces the sterile air to the power input of micro-plants and the oxygen of aerobic processes; important economic technical profits is foreseen; microplants distinguishes by small installations for compressed air and the services with overall automatic control available; the reliable performance for the human health, variable speed and standard impeller system, simple sterilization, safe sampling and supplies, foam-breaks to avoiding chemicals and simple automatic flow control distinguish the installations. The mathematical simulation of G-reactor performances to the mixing operations at gas-liquid systems to mass-transfer is shown; a solved example to a specific process illustrates the calculus fundamentals; the software enables the calculus of consumption parameters to the reactor scale-up and micro-plants of maximum capacity; the descriptive data analysis is discussed for the primary technical evaluations and general conclusions. The innovation is proposed for the small production scale of drugs and the unit operations of the chemical industry; a brief technical description of micro-plants and the production of sterile air may lead to the process engineering and the preliminary analysis of costs. The prophylactic treatment of the residual gas flow is shown.
Keywords: Biological Risks; Reactor Design; Stirrer Reactor; Gas-Liquid; Mass-Transfer; Unit Operations
